Generics

Teva debuts generic Narcan

Teva’s generic Narcan provides a treatment for opioid emergencies.
Camber intros generic Adderall XR

The medication is indicated for the treatment of attention deficit hyperactivity disorder.
Cipla gains FDA blessing for generic Somatuline Depot

Somatuline Depot injection has a market value of approximately $867 million for the 12 months ending October 2021, according to IQVIA.
Hikma launches bupivacaine HCl injection

Bupivacaine HCl injection had a market value of approximately $64 million in the 12 months ending October 2021.
Alembic obtains FDA approval, tentative OK for 2 generics

The Food and Drug Administration has given Alembic clearance for formoterol fumarate inhalation solution and tentative approval for selexipag tablets in various dosage strengths.
Eagle obtains 180 days marketing exclusivity for generic Vasostrict

Eagle Pharmaceuticals received 180 days of marketing exclusivity from the Food and Drug Administration for its recently approved generic version of Endo’s Vasostrict (vasopressin).
Alembic intros generic Bactroban

Alembic's generic Bactroban provides a treatment for secondarily infected traumatic skin lesions due to susceptible isolates of Staphylococcus aureus and Streptococcus pyogenes.
ANI gets FDA OK for generic Mycobutin

Rifabutin capsules have a market value of approximately $16.6 million, according to IQVIA.

U.S. Court of Appeals for the Federal Circuit upholds validity of Novartis’ Gilenya dosage regimen patent